• head_banner_01

단백질 합성에 사용되는 아미노산의 불순물

짧은 설명 :

NO

제품

CAS NO

1

fmoc-d-ala-d-ala-oh

NA

2

FMOC-β-ALA-D-ALA-OH

NA

3

FMOC-ARG (PBF) -ARG (PBF) -OH

NA


제품 세부 사항

제품 태그

제품 세부 사항

NO

제품

CAS NO

주요 품질 표시기

청정

맥스.

불결

총 용매 잔류 물

수분

1

FMOC-β-ALA-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

2

fmoc-d-ala-d-ala-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

3

FMOC-β-ALA-D-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

4

FMOC-ARG (PBF) -ARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

5

FMOC-β-ALA-ARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

6

fmoc-d-arg (pbf) -d-arg (pbf) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

7

FMOC-β-ALA-D-ARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

8

FMOC-HOMOARG (PBF) -homoarg (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

9

FMOC-β-ALA-HOMOARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

10

fmoc-asn (trt) -asn (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

11

FMOC-β-ALA-ASN (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

12

fmoc-asp (otbu) -asp (otbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

13

FMOC-β-ALA-ASP (OTBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

14

fmoc-cys (trt) -cys (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

15

FMOC-β-ALA-CYS (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

16

fmoc-cys (acm) -cys (ACM) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

17

FMOC-β-ALA-CYS (ACM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

18

FMOC-GLN (TRT) -GLN (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

19

FMOC-β-ALA-GLN (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

20

fmoc-glu (otbu) -glu (otbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

21

FMOC-β-ALA-GLU (OTBU) -OH.H2O

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

22

FMOC-β-ala-Gly-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

23

FMOC-HIS (TRT) -HIS (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

24

FMOC-β-ALA-HIS (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

25

FMOC-ILE-ILE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

26

FMOC-β-ala-Ile-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

27

FMOC-LEU-LEU-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

28

FMOC-β-ALA-LEU-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

29

FMOC-D-LEU-D-LEU-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

30

FMOC-β-ALA-D-LEU-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

31

fmoc-lys (boc) -lys (boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

32

FMOC-β-ALA-LYS (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

33

fmoc-lys (alloc) -lys (alloc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

34

fmoc-β-ala-lys (Alloc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

35

FMOC-Met-Met-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

36

FMOC-β-ALA-MET-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

37

fmoc-orn (boc) -orn (boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

38

FMOC-β-ALA-ER (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

39

fmoc-phe-phe-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

40

FMOC-β-ALA-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

41

fmoc-d-phe-d-phe-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

42

FMOC-β-ALA-D-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

43

fmoc-pro-pro-oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

44

FMOC-β-ALA-PO-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

45

fmoc-ser (tbu) -ser (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

46

FMOC-β-ALA-SER (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

47

fmoc-ser (trt) -ser (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

48

FMOC-β-ALA-SER (TRT) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

49

fmoc-thr (tbu) -thr (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

50

FMOC-β-ALA-THR (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

51

fmoc-trp (boc) -trp (boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

52

FMOC-β-ALA-TRP (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

53

FMOC-D-TRP (BOC) -D-TRP (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

54

FMOC-β-ALA-D-TRP (BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

55

fmoc-tyr (tbu) -tyr (tbu) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

56

FMOC-β-ALA-TYR (TBU) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

57

fmoc-d-tyr (et) -d-tyr (et) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

58

FMOC-β-ALA-D-TYR (ET) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

59

fmoc-tyr (me) -tyr (me) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

60

fmoc-β-ala-tyr (me) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

61

FMOC-VAL-VAL-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

62

FMOC-β-ALA-VAL-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

63

FMOC-D-CIT-D-CIT-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

64

FMOC-β-ALA-D-CIT-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

65

FMOC-β-ALA-DAB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

66

FMOC- (3- (2- 나프 틸) -D-ALA) 2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

67

FMOC-β-ALA-3- (2- 나프 틸) -D-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

68

FMOC- (3- (3- 피리 디 닐) -D-ALA) 2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

69

FMOC-β-ALA-3- (3- 피리 디 닐) -D-ALA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

70

FMOC- (4- 클로로 -D-PHE) 2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

71

FMOC-β-ALA-4- 클로로 -D-PHE-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

72

FMOC- (D-4APH (TBUCBM)) 2-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

73

FMOC-β-ALA-D-4APH (TBUCBM) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

74

fmoc-aph (l-hor) -aph (l-hor) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

75

FMOC-β-ALA-APH (L-HOR) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

76

fmoc-lys (ipr, boc) -lys (ipr, boc) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

77

FMOC-β-ALA-LYS (IPR, BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

78

FMOC-β-ALA-EAEA-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

79

FMOC-AIB-AIB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

80

FMOC-β-ALA-AIB-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

81

FMOC-ARG-OH

91000-69-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

82

H-ARG (PBF) -OH

200115-86-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

83

FMOC-D-ARG-OH

130752-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

84

HD-ARG (PBF) -OH

200116-81-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

85

FMOC-HOMOARG-OH.HCL

208174-14-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

86

H-Homoarg (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

87

FMOC-D-HOMOARG-OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

88

HD-HOMOARG (PBF) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

89

FMOC-ASN-OH

71989-16-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

90

H-ASN (TRT) -OH

132388-58-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

91

FMOC-ASP-OH

119062-05-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

92

h-asp (otbu) -oh

3057-74-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

93

FMOC-CYS-OH

135248-89-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

94

h-cys (trt) -oh

2799/7/7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

95

H-Cys (ACM) -oh.hcl

28798-28-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

96

FMOC-GLN-OH

71989-20-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

97

H-GLN (TRT) -OH

102747-84-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

98

fmoc-glu-oh

121343-82-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

99

H-Glu (OTBU) -oh.h2o

2419-56-9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

100

FMOC-HIS-OH

116611-64-4

≥98.0%

≤1.0%

≤8.0%

≤2.0%

101

H-HIS (TRT) -OH

35146-32-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

102

Boc-his-oh

17791-52-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

103

FMOC-LYS-OH

105047-45-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

104

H-Lys (BOC) -OH

2418-95-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

105

H-Lys (Alloc) -oh

6298/3/9

≥98.0%

≤1.0%

≤8.0%

≤2.0%

106

fmoc-orn-oh.hcl

201046-57-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

107

h-nor (Boc) -oh

13650-49-2

≥98.0%

≤1.0%

≤8.0%

≤2.0%

108

FMOC-SER-OH

73724-45-5

≥98.0%

≤1.0%

≤8.0%

≤2.0%

109

H-Ser (TBU) -oh

18822-58-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

110

H-Ser (trt) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

111

fmoc-thr-oh.h2o

73731-37-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

112

H-THR (TBU) -OH

4378-13-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

113

FMOC-TRP-OH

35737-15-6

≥98.0%

≤1.0%

≤8.0%

≤2.0%

114

H-TRP (BOC) -OH

146645-63-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

115

FMOC-D-TRP-OH

86123-11-7

≥98.0%

≤1.0%

≤8.0%

≤2.0%

116

HD-TRP (BOC) -OH

201290-11-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

117

FMOC-TYR-OH

92954-90-0

≥98.0%

≤1.0%

≤8.0%

≤2.0%

118

H-Tyr (TBU) -OH

18822-59-8

≥98.0%

≤1.0%

≤8.0%

≤2.0%

119

fmoc-d-tyr-oh

112883-29-1

≥98.0%

≤1.0%

≤8.0%

≤2.0%

120

HD-Tyr (ET) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

121

h-tyr (me) -oh.hcl

67423-44-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

122

FMOC-D-4APH (CBM) -OH

324017-22-3

≥98.0%

≤1.0%

≤8.0%

≤2.0%

123

hd-4aph (tbucbm) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

124

fmoc-lys (ipr) -oh

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

125

H-Lys (IPR, BOC) -OH

NA

≥98.0%

≤1.0%

≤8.0%

≤2.0%

에 대한

보상

Gentolex는 훌륭한 품질의 제품을 제공합니다. 필요한 기간 내에 고객이 제품 품질을 충분히 증명하여 제기하면 보상 절차를 트리거하는 데 필요한 분석 및 평가를 제공 할 것입니다.

생산

제약 제품의 능력은 톤 등급에 도달했으며 화학 제품의 역량은 100tons+ 등급에 도달하며 기능은 전 세계 고객에게 서비스를 제공 할 수있는 장비가 잘 갖추어져 있습니다.

연구 개발

매년 R & D 팀이 다양한 신제품을 개발할 계획이 있으며, 목표가 설정되면 팀의 모든 구성원은 KPI 책임과 인센티브 정책을 수행해야합니다.


  • 이전의:
  • 다음:

  • 여기에 메시지를 작성하여 우리에게 보내십시오